New french questionnaire aims to catch Alzheimer's navigation trouble early
NCT ID NCT07616063
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a French questionnaire designed to identify spatial orientation problems in people with Alzheimer's disease. Researchers will ask 330 participants—including Alzheimer's patients, their caregivers, and healthy older adults—to fill out the questionnaire. The goal is to see if the tool is reliable and useful for spotting early signs of disorientation, which could lead to better care and support.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Questionnaire d'Orientation Spatiale (QOS) - a French version of the Wayfinding Questionnaire
What this could lead to
If successful, this questionnaire could become a standard tool to detect spatial disorientation early in Alzheimer's, helping doctors provide better support.
What could go wrong
This is an early-stage validation study, not a treatment trial. The questionnaire may not prove accurate enough for routine use, and results may not apply outside French-speaking populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU (Centre Hospitalier Régionale Universitaire) Nancy
Nancy, 54500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact